ClinicalTrials.gg
Sign In

Adrenal Hyperplasia, Congenital clinical trials

The registry lists 101 studies for Adrenal Hyperplasia, Congenital across more than 10 countries. 28 are recruiting or about to start. 85 of them are mainly about Adrenal Hyperplasia, Congenital (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-12.

Get an email when these change. Save the Adrenal Hyperplasia, Congenital studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
44
Recruiting
20
Status unknown
13
Not yet recruiting
8
Terminated
6
Active, not recruiting
5

Phase

Phase 2
30
Phase 1
11
Phase 3
11
Phase 4
3

Where

United States
50
France
21
Italy
16
United Kingdom
14
Germany
10
Brazil
9

Who runs them

Neurocrine UK Limited (8) · Neurocrine Biosciences (6) · Assistance Publique - Hôpitaux de Paris (6) · Spruce Biosciences (5) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (4) · Crinetics Pharmaceuticals Inc. (4) · Hospices Civils de Lyon (4) · IRCCS Azienda Ospedaliero-Universitaria di Bologna (3)

What is being tested here

Drugs under test in Adrenal Hyperplasia, Congenital studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Atumelnant324
Asedebart202
Osilodrostat202
Hydrocortisone1617
Crinecerfont126
Metyrapone102
Tildacerfont003
Pd-132301 hydrochloride002
Dexamethasone002
Abiraterone Acetate002

Drug classes tested here Corticosteroids 1 open

Coming up

4phase 3 studies under way
9studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 9, phase 3 first

Who these studies take

Of the 20 Adrenal Hyperplasia, Congenital studies recruiting now, 10 (50%) set no upper age limit and 9 (45%) stop at 75 or younger. 7 (35%) take children under 18. 2 (10%) are for women only and 1 (5%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 20
AgeWomenMen
104 (20%)4 (20%)
1817 (85%)16 (80%)
3017 (85%)16 (80%)
4016 (80%)15 (75%)
5016 (80%)15 (75%)
6516 (80%)15 (75%)
7511 (55%)11 (55%)
8510 (50%)10 (50%)

Across all 101 studies, recruiting or not: 57% stop at 75 or younger and 50% at 65; 51% take children; 10% are for women only and 4% for men only; 22% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

What changed recently

From the registry's own updates since Oct 15, 2026.

Newly registered1

Studies

Recruiting first, then most recently updated. Showing 50 of 101. Browse all 101 → or search them.